Pegfilgrastim
Showing 1 - 25 of 366
Pegfilgrastim, Bone Pain, Chemo Trial (Timing of pegfilgrastim administration)
Not yet recruiting
- Pegfilgrastim
- +4 more
- Timing of pegfilgrastim administration
- (no location specified)
Apr 21, 2023
Quality and Quantity of M-PRP Cellular Content Filgrastim vs.
Recruiting
- Healthy
- Filgrastim
- Pegfilgrastim
-
Gulf Breeze, FloridaAndrews Research and Education Foundation
Oct 6, 2022
Myeloma Multiple, Lymphoma Trial in Monterrey (Pegfilgrastim)
Recruiting
- Myeloma Multiple
- Lymphoma
- Pegfilgrastim
-
Monterrey, Nuevo León, MexicoHospital Universitario Dr. José Eleuterio González
Apr 18, 2022
Patient Preference BetweenPrefilled Syringe orPrefilled Pen
Recruiting
- Patient Preference
- +2 more
- PELGRAZ prefilled syringe or PELGRAZ prefilled pen
-
Levallois-Perret, Ile-de-France, FranceInstitut Rafael
Jun 19, 2023
Neutropenia Trial in Beijing (Pegfilgrastim)
Completed
- Neutropenia
- Pegfilgrastim
-
Beijing, Beijing, ChinaDepartment of Medical Oncology
Mar 12, 2022
HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)
Recruiting
- HER2-positive Breast Cancer
- Operable Breast Cancer
- Trastuzumab + Paclitaxel
- Pegfilgrastim
-
Avignon, France
- +8 more
Jan 9, 2023
Neutropenia Trial in Montevideo (Pegfilgastrim Megalabs, Pegfilgastim Amgen)
Recruiting
- Neutropenia
- Pegfilgastrim Megalabs
- Pegfilgastim Amgen
-
Montevideo, BrazilMarcos Giusti
Apr 8, 2022
Breast Tumors Trial in Busan (Eflapegrastim)
Not yet recruiting
- Breast Neoplasms
-
Busan, Korea, Republic ofGood Gang-An Hospital
Jul 9, 2023
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Advanced Soft-tissue Sarcoma Trial in Santa Monica (Camsirubicin)
Recruiting
- Advanced Soft-tissue Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Center
Sep 16, 2021
Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)
Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,
Recruiting
- Stage II Bladder Cancer AJCC v8
- +2 more
- Cisplatin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)
Not yet recruiting
- Lymphoma
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Apr 18, 2023
Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,
Recruiting
- Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
- +13 more
- Cyclophosphamide
- +6 more
-
Scottsdale, Arizona
- +2 more
Jun 1, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +5 more
- Blinatumomab
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Lymphoma Trial (pegfilgrastim, rituximab, cyclophosphamide)
Completed
- Lymphoma
- pegfilgrastim
- +5 more
- (no location specified)
Jul 2, 2021
Early-stage Breast Cancer Trial in Ottawa (Filgrastim, Pegfilgrastim)
Recruiting
- Early-stage Breast Cancer
- Filgrastim
- Pegfilgrastim
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Jun 10, 2021
Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Rituximab
- +5 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 12, 2022
Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte
Not yet recruiting
- Early-stage Breast Cancer
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Feb 22, 2023
Alcoholic Hepatitis Trial in United States (Standard of care + pegfiltrastim, Standard of care)
Completed
- Alcoholic Hepatitis
- Standard of care + pegfiltrastim
- Standard of care
-
Loma Linda, California
- +4 more
Sep 23, 2021
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)
Not yet recruiting
- Ovarian Cancer
- +4 more
- Luveltamab tazevibulin
- Pegfilgrastim
- (no location specified)
May 12, 2023
Safety and Efficacy of Pegfilgrastim (Neulasta®)
Completed
- Breast Cancer Female
- Breast Neoplasm Female
-
Wonju, Gangwon, Korea, Republic of
- +2 more
Aug 30, 2021